eli lilly news glp-1 The FDA approved a new pill from on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Inside the GLP-1 Gold Rush:

Ours stays accessible and transparent

Today, around 70% of all people with overweight or obesity live in low- and middle-income countries, where obesity rates are increasing faster than in rich nations due to lack of access to nutritious foods and increasingly sedentary lifestyles

Chervonsky AV

Oral GLP-1 Approaches Commercial Inflection by 2028 GLP-1 Weight Loss Drug Market Revenue Share, CAGR, and Primary Drivers by Route 2026 Subcutaneous injectable administration commands 81.7% GLP-1 market revenue share in 2026 as the weekly autoinjector format delivers clinical efficacy, dose consistency, and patient convenience superior to daily injectable alternatives

You might start asking yourself, is it okay to take creatine with caffeine

Legal experts at Orrick estimate the full rulemaking process takes 12 to 24 months from a favorable vote